BOSTON - Inhibikase Therapeutics, Inc. (NASDAQ ... including Arena's acquisition by Pfizer (NYSE:PFE) and Longboard Pharmaceuticals' acquisition by Lundbeck A/S. Dr. Cabell, with his extensive ...

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics ... the formation of Arena's spinout and served on the Board of Longboard Pharmaceuticals, which was recently acquired by Lundbeck ...

BOSTON - Inhibikase Therapeutics, Inc. (NASDAQ ... including Arena's acquisition by Pfizer (NYSE:PFE) and Longboard Pharmaceuticals' acquisition by Lundbeck A/S. Dr. Cabell, with his extensive ...

Biotechnology company United Therapeutics (NASDAQ:UTHR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $735.9 million. Its GAAP profit of $6.19 per ...

Piotr Swat / SOPA Images / LightRocket via Getty Images Summit Therapeutics shares dropped 14% Monday as it reported a fourth-quarter adjusted loss nearly double that of the previous year.

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

In a report released today, Sarah Schram from William Blair maintained a Buy rating on Ovid Therapeutics (OVID – Research Report). The company’s shares closed yesterday at $0.49. Effectively ...

Viking Global's 13F stock portfolio increased from $27.44B to $30.90B, with holdings rising from 83 to 86. Read more to see ...

A digital therapeutics start-up which uses augmented reality (AR) glasses to aid people suffering from disorders including Parkinson's disease and multiple sclerosis will this week announce a £ ...

PITTSBURGH, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing ...